Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with Q waves in hypertrophic cardiomyopathy

Journal of Cardiovascular Magnetic Resonance

Volumn 9, Issue 3, 2007, Pages 595-603

  Papavassiliu, Theano ^a   Flüchter, Stephan ^a   Haghi, Dariusch ^a   Süselbeck, Tim ^a   Wolpert, Christian ^a   Dinter, Dietmar ^a   Kühl, Harald ^b   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Abnormal Q Waves; Cardiovascular Magnetic Resonance; Hypertrophic Cardiomyopathy

Indexed keywords

GADOLINIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE;

CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33947273755     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640600945465     Document Type: Article

References (35)

1. Hollister RM, Goodwin JF Electrocardiogram in cardiomyopathy. BR Heart J 1963;25:357-74.
2. Maron BJ. Q waves in hypertrophic cardiomyopathy: A reassessment. J Am Coll Cardiol 1990;16:375-76.
3. Maron BJ, Wolfson JK, Ciro E, et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 1983;51:189-94.
4. Lemery R, Kleinebenne A, Nihoyannopoulos P, et al. Q wave in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol 1990;16:368-74.
5. Bahl OP, Walsh TJ, Massie E. Electrocardiography and vectorcardiography in idiopathic hypertrophic subaortic stenosis. Am J Med Scie 1970;259:262-71.
6. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086-102.
7. Cosio FG, Moro C, Alonso M, de la Calzada CS, Liovet A. The Q waves hypertrophic cardiomyopathy: an electrophysiologic study. N Engl J Med. 1980 Jan 10;302(2):96-9.
8. Coltart DJ, Meldrum SJ. Hypertrophic cardiomyopathy. An electrophysiological study. Br Med J. 1970 24;4(729):217-8.
9. Savage DD, Seides SF, Clark CE, Henry WL, Maron BJ, Robinson FC, Epstein SE. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1978;58:402-8.
10. Brackbill TA, Shah PM. Vectorcardiographic comparison of left ventricular hypertrophy in idiopathic hypertrophic subaortic stenosis, aortic stenosis, and aortic regurgitation. Am Heart J 1974;88(3):269-76.
11. McKenna WJ, Borggrefe M, England D, Deanfield J, Oakley CM, Goodwin JF. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation 1982;66(6):1233-40.
12. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 1968;37(5):759-88.
13. Wigle ED, Baron RH. The electrocardiogram in muscular subaortic stenosis. Effect of a left septal incision and right bundle-branch block. Circulation 1966;34(4):585-94.
14. Braudo M, Wigle ED, Keith JD. A distinctive electrocardiogram in muscular subaortic stenosis due to ventricular septal hypertrophy. Am J Cardiol 1964;14:599-607.
15. Mori H, Ogawa S, Noma S, Fujii I, Hayashi J, Yamazaki H, Nakazawa H, Handa S, Nakamura Y. Pattern of myocardial hypertrophy as a possible determinant of abnormal Q waves in hypertrophic cardiomyopathy. Jpn Circ J 1983;47(5):513-21.
16. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. J Am Coll Cardiol 1986;8(1):57-65.
17. Koga Y, Yamaga A, Hiyamuta K, Ikeda H, Toshima H. Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. Cardiovasc Electrophysiol 2004;15(12):1402-8.
18. Wu E, Judd RM, Vargas JD, Klocke FJ, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8.
19. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
20. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J AmColl Cardiol 2000;36:1985-91.
21. Choudhury L, Mahrholdt H,Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40(12):2156-64.
22. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;16;43(12):2260-4.
23. Report of the1995 World Health Organisation. International Society and Federation of Cardiomyopathy Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
24. Simonetti OP, Kim RJ, Fieno DS. et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23.
25. Cerqueira MD, Weissman NJ, Dilsizian V. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation 2002;105:539-42.
26. Comte A, lalande A, Walker PM, Cochet A, Legrand L, Cottin Y, Wolf JE, Brunotte F.Visual estimation of the global myocardial extent of hyperenhancement on delayed contrast-enhanced MRI. Eur Radiol 2004;14(12):2182-7.
27. Konno T, Shimizu M, Ino H, Yamaguchi M, Terai H, Uchiyama K, Oe K, Mabuchi T, Kaneda T, Mabuchi H. Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 2004;25(3):246-51.
28. Charron PH, Dubourg O, Desnos M. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997;6:214-9.
29. Ryan MP, Cleland JGF, French JA. et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995;76:689-94.
30. Charron PH, Dubourg O, Desnos M. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998;19:1377-82.
31. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-45.
32. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26(15):1461-74.
33. Papavassiliu T, Schnabel P, Schröder M, Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings offibrosis. Eur Heart J 2005;26(22):2395.
34. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986;55(6):575-81.
35. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41(9):1561-7.